FibroBiologics raises $1.02M via $1.2M convertible debenture to Peak One; 15% OID, 0% interest

FibroBiologics, Inc.

Issued $1.2M principal convertible debenture to Peak One Opportunity Fund for $1,020,000 cash, a 15% original issue discount, plus 125,000 restricted commitment shares and a $20,000 fee.
Debenture matures Oct 8, 2027, pays 0% interest, and is convertible at $0.78/share only after an Event of Default; default allows 18% interest and 120% acceleration.
Company must pay $1,080,000 on Apr 8, 2027, $60,000 on Jul 8, 2027, and $60,000 or remaining balance at maturity; holder can require 50% of cash proceeds over $1.5M be used to repay.
Exchange cap limits issuance to 1,671,094 shares absent stockholder approval; 4.99% beneficial ownership blocker applies; no variable-rate transactions while debenture outstanding.
Company may redeem at 100% principal anytime no Event of Default; proceeds solely for business operations.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.